Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Kakar

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Preventive Medicine|July 12, 2012
Preventive medicine in the older patient: a United kingdom perspectivePuneet Kakar
Expert Review of Neurotherapeutics|November 3, 2006
Atrial fibrillation and stroke preventionPuneet Kakar, Gregory Y H Lip
Expert Review of Cardiovascular Therapy|May 11, 2007
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapyPuneet Kakar, Gregory Y H Lip
JRSM Cardiovascular Disease|November 1, 2013
Cerebral microbleeds: a new dilemma in stroke medicinePuneet Kakar, Andreas Charidimou, David J Werring
Chest|November 14, 2006
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schemaPuneet Kakar, Deirdre Lane, Gregory Y H Lip
Current Opinion in Investigational Drugs (London, England : 2000)|April 6, 2007
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor XPuneet Kakar, Timothy Watson, Gregory Y H Lip
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2007
RivaroxabanPuneet Kakar, Timothy Watson, Gregory Y H Lip
Expert Review of Neurotherapeutics|December 22, 2006
Stroke: ethnic differences do existPuneet Kakar, Ashan Gunarathne, Gregory Y H Lip
The American Journal of Cardiology|May 29, 2007
Cardioversion for atrial fibrillation: does inflammation matter?Timothy Watson, Puneet Kakar, Gregory Y H Lip
International Journal of Clinical Practice|January 19, 2007
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closelyTimothy Watson, Puneet Kakar, Gregory Y H Lip
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Preventive Medicine|July 12, 2012
Preventive medicine in the older patient: a United kingdom perspectivePuneet Kakar
Expert Review of Neurotherapeutics|November 3, 2006
Atrial fibrillation and stroke preventionPuneet Kakar, Gregory Y H Lip
Expert Review of Cardiovascular Therapy|May 11, 2007
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapyPuneet Kakar, Gregory Y H Lip
JRSM Cardiovascular Disease|November 1, 2013
Cerebral microbleeds: a new dilemma in stroke medicinePuneet Kakar, Andreas Charidimou, David J Werring
Chest|November 14, 2006
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schemaPuneet Kakar, Deirdre Lane, Gregory Y H Lip
Current Opinion in Investigational Drugs (London, England : 2000)|April 6, 2007
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor XPuneet Kakar, Timothy Watson, Gregory Y H Lip
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2007
RivaroxabanPuneet Kakar, Timothy Watson, Gregory Y H Lip
Expert Review of Neurotherapeutics|December 22, 2006
Stroke: ethnic differences do existPuneet Kakar, Ashan Gunarathne, Gregory Y H Lip
The American Journal of Cardiology|May 29, 2007
Cardioversion for atrial fibrillation: does inflammation matter?Timothy Watson, Puneet Kakar, Gregory Y H Lip
International Journal of Clinical Practice|January 19, 2007
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closelyTimothy Watson, Puneet Kakar, Gregory Y H Lip
Pageof 4